BioSpace News Archive

Biocept, Inc . (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve the outcomes of patients with cancer, announces the availability of 10,000 nasopharyngeal specimen collection kits for RT-PCR testing for SAR-CoV-2 (COVID-19) for physician

Preclinical data demonstrated statistically significant tumor reduction in SM-88 treated arms versus controls - Builds on confirmed tumor responses achieved in human clinical studies across 15 different cancer types - Multiple monotherapy effects of SM-88 were shown, including increased oxidative stress, disruption of autophagy, and tumor immunomodulation - Preclinical results were demonstrated across multiple tumor types including, pancreatic

Innovatus Capital Partners, LLC (“Innovatus” or the “Firm”), an independent adviser and portfolio management firm with approximately $1.6 billion in assets under management, today announced that it has appointed Geoffrey Duyk, M.D., Ph.D., the founder and Managing Partner of Circularis LP, to its Life Sciences Advisory Board.

First subjects recently administered immunizations in two studies of 20-valent pneumococcal conjugate vaccine candidate in infants; a pentavalent meningococcal vaccine candidate in adolescents; and a respiratory syncytial virus vaccine candidate in pregnant women

MedTech Innovator , the premier nonprofit accelerator in the medical technology industry, today announced the 50 companies selected to participate in the organization’s flagship four-month Showcase and Accelerator program, featuring the industry’s most transformative device, diagnostic, and digital health technologies from around

Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI) , a medical device company focused on the design and development of single-port robotic surgical technologies, announces that on June 18, 2020, The Nasdaq Stock Market LLC (“Nasdaq”) staff determined that the Company has cured the Market Value of Listed Securities and bid price deficiencies and has regained full compliance with all applicable criteria for c

Caprion-HistoGeneX offers COVID-19 PCR testing services in partnership with Clinical Logistics, a virtual central laboratory for a complete and worry-free service from sample collection to easy-to-interpret reports.

Mainstay Medical Holdings plc announced that the U.S. Food and Drug Administration has approved the Company’s Premarket Approval application for ReActiv8®, its implantable neurostimulation system to treat intractable chronic low back pain.

MAX32670 saves 40 percent power and 50 percent space, includes ECC-protected memory for increased equipment uptime

Start Codon aims to rapidly translate the most disruptive and innovative life science research into successful companies and positive clinical outcomes